{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:26:07Z","timestamp":1777307167171,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s40618-019-01025-6","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T14:08:41Z","timestamp":1550844521000},"page":"1041-1049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Reliability of calcium\u2013phosphorus (Ca\/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca\u2013P disorders"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2881-982X","authenticated-orcid":false,"given":"B.","family":"Madeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-5683","authenticated-orcid":false,"given":"S.","family":"De Vincentis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1892-9785","authenticated-orcid":false,"given":"F.","family":"Vescini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Trenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5724-3914","authenticated-orcid":false,"given":"G.","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-0696","authenticated-orcid":false,"given":"V.","family":"Rochira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"1025_CR1","volume-title":"Endotext","author":"JL Shaker","year":"2000","unstructured":"Shaker JL, Deftos L (2000) Calcium and phosphate homeostasis. In: De Groot LJ, Chrousos G, Dungan K et al (eds) Endotext. MDText.com Inc, South Dartmouth (MA)"},{"issue":"Suppl 1","key":"1025_CR2","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.2215\/CJN.05910809","volume":"5","author":"M Peacock","year":"2010","unstructured":"Peacock M (2010) Calcium metabolism in health and disease. Clin J Am Soc Nephrol 5(Suppl 1):S23\u2013S30","journal-title":"Clin J Am Soc Nephrol"},{"key":"1025_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jbm4.10019","volume":"2","author":"B Madeo","year":"2018","unstructured":"Madeo B, Kara E, Cioni K, Vezzani S, Trenti T, Santi D, Simoni M, Rochira V (2018) Serum calcium to phosphorous (Ca\/P) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism. JBMR Plus 2:109\u2013117","journal-title":"JBMR Plus"},{"key":"1025_CR4","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99:3561\u20133569","journal-title":"J Clin Endocrinol Metab"},{"key":"1025_CR5","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Cetani F (2011) Clinical practice. Primary hyperparathyroidism. N Engl J Med 365:2389\u20132397","journal-title":"N Engl J Med"},{"key":"1025_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374:145\u2013158","journal-title":"Lancet"},{"key":"1025_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","volume":"73","author":"ML Griebeler","year":"2015","unstructured":"Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA (2015) Secular trends in the incidence of primary hyperparathyroidism over five decades (1965\u20132010). Bone 73:1\u20137","journal-title":"Bone"},{"key":"1025_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.beem.2018.06.004","volume":"32","author":"M Christov","year":"2018","unstructured":"Christov M, Juppner H (2018) Phosphate homeostasis disorders. Best Pract Res Clin Endocrinol Metab 32:685\u2013706","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1025_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s40618-018-0849-5","volume":"41","author":"JM Boland","year":"2018","unstructured":"Boland JM, Tebben PJ, Folpe AL (2018) Phosphaturic mesenchymal tumors: what an endocrinologist should know. J Endocrinol Investig 41:1173\u20131184","journal-title":"J Endocrinol Investig"},{"key":"1025_CR10","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","volume":"118","author":"A Gaasbeek","year":"2005","unstructured":"Gaasbeek A, Meinders AE (2005) Hypophosphatemia: an update on its etiology and treatment. Am J Med 118:1094\u20131101","journal-title":"Am J Med"},{"key":"1025_CR11","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s00198-018-4618-2","volume":"29","author":"G Marcucci","year":"2018","unstructured":"Marcucci G, Masi L, Ferrari S, Haffner D, Javaid MK, Kamenicky P, Reginster JY, Rizzoli R, Brandi ML (2018) Phosphate wasting disorders in adults. Osteoporos Int 29:2369\u20132387","journal-title":"Osteoporos Int"},{"key":"1025_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1097\/QAD.0000000000001067","volume":"30","author":"JL Casado","year":"2016","unstructured":"Casado JL, Santiuste C, Vazquez M, Banon S, Rosillo M, Gomez A, Perez-Elias MJ, Caballero C, Rey JM, Moreno S (2016) Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients. Aids 30:1423\u20131431","journal-title":"Aids"},{"key":"1025_CR13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/135965350901400404","volume":"14","author":"CI Bagnis","year":"2009","unstructured":"Bagnis CI, Karie S, Deray G, Essig M (2009) Hypophosphataemia: an easy strategy for diagnosis and treatment in HIV patients. Antivir Ther 14:481\u2013488","journal-title":"Antivir Ther"},{"key":"1025_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","volume":"23","author":"P Labarga","year":"2009","unstructured":"Labarga P, Barreiro P, Martin-Carbonero L et al (2009) Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. Aids 23:689\u2013696","journal-title":"Aids"},{"key":"1025_CR15","doi-asserted-by":"publisher","first-page":"e28512","DOI":"10.1371\/journal.pone.0028512","volume":"6","author":"V Rochira","year":"2011","unstructured":"Rochira V, Zirilli L, Orlando G, Santi D, Brigante G, Diazzi C, Carli F, Carani C, Guaraldi G (2011) Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PLoS One 6:e28512","journal-title":"PLoS One"},{"key":"1025_CR16","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1373\/clinchem.2018.291377","volume":"64","author":"JD Smith","year":"2018","unstructured":"Smith JD, Wilson S, Schneider HG (2018) Misclassification of calcium status based on albumin-adjusted calcium: studies in a tertiary hospital setting. Clin Chem 64:1713\u20131722","journal-title":"Clin Chem"},{"key":"1025_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0002-9343(84)90525-4","volume":"77","author":"JC Boyd","year":"1984","unstructured":"Boyd JC, Ladenson JH (1984) Value of laboratory tests in the differential diagnosis of hypercalcemia. Am J Med 77:863\u2013872","journal-title":"Am J Med"},{"key":"1025_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0025-7125(16)32936-4","volume":"52","author":"LV Avioli","year":"1968","unstructured":"Avioli LV (1968) The diagnosis of primary hyperparathyroidism. Med Clin N Am 52:451\u2013462","journal-title":"Med Clin N Am"},{"key":"1025_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.7326\/0003-4819-68-1-188","volume":"68","author":"CA Strott","year":"1968","unstructured":"Strott CA, Nugent CA (1968) Laboratory tests in the diagnosis of hyperparathyroidism in hypercalcemic patients. Ann Intern Med 68:188\u2013202","journal-title":"Ann Intern Med"},{"key":"1025_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0025-7125(16)32680-3","volume":"54","author":"E Reiss","year":"1970","unstructured":"Reiss E (1970) Primary hyperparathyroidism: a simplified approach to diagnosis. Med Clin N Am 54:131\u2013139","journal-title":"Med Clin N Am"},{"key":"1025_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.eururo.2015.07.040","volume":"69","author":"C Turk","year":"2016","unstructured":"Turk C, Petrik A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T (2016) EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 69:468\u2013474","journal-title":"Eur Urol"},{"key":"1025_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","volume":"192","author":"MS Pearle","year":"2014","unstructured":"Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192:316\u2013324","journal-title":"J Urol"},{"key":"1025_CR23","doi-asserted-by":"publisher","first-page":"i52","DOI":"10.1136\/bmj.i52","volume":"352","author":"MS Morgan","year":"2016","unstructured":"Morgan MS, Pearle MS (2016) Medical management of renal stones. BMJ 352:i52","journal-title":"BMJ"},{"key":"1025_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40620-016-0329-y","volume":"29","author":"G Gambaro","year":"2016","unstructured":"Gambaro G, Croppi E, Coe F et al (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29:715\u2013734","journal-title":"J Nephrol"},{"key":"1025_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161435.GL","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, Petak SM, Binkley N et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142016. Endocr Pract 22:1\u201342","journal-title":"Endocr Pract"},{"key":"1025_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4081\/reumatismo.2016.870","volume":"68","author":"M Rossini","year":"2016","unstructured":"Rossini M, Adami S, Bertoldo F et al (2016) Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo 68:1\u201339","journal-title":"Reumatismo"},{"key":"1025_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11739-018-1874-2","volume":"14","author":"R Nuti","year":"2018","unstructured":"Nuti R, Brandi ML, Checchia G et al (2018) Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med 14:85\u2013102","journal-title":"Intern Emerg Med"},{"key":"1025_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/andr.12470","volume":"6","author":"V Rochira","year":"2018","unstructured":"Rochira V, Antonio L, Vanderschueren D (2018) EAA clinical guideline on management of bone health in the andrological outpatient clinic. Andrology 6:272\u2013285","journal-title":"Andrology"},{"key":"1025_CR29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s40618-016-0434-8","volume":"39","author":"F Vescini","year":"2016","unstructured":"Vescini F, Attanasio R, Balestrieri A et al (2016) Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. J Endocrinol Invest 39:807\u2013834","journal-title":"J Endocrinol Invest"},{"key":"1025_CR30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.maturitas.2013.05.013","volume":"75","author":"J Compston","year":"2013","unstructured":"Compston J, Bowring C, Cooper A et al (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 75:392\u2013396","journal-title":"Maturitas"},{"key":"1025_CR31","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1210\/jc.2014-4432","volume":"100","author":"G Chen","year":"2015","unstructured":"Chen G, Xue Y, Zhang Q et al (2015) Is normocalcemic primary hyperparathyroidism harmful or harmless? J Clin Endocrinol Metab 100:2420\u20132424","journal-title":"J Clin Endocrinol Metab"},{"key":"1025_CR32","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","volume":"341","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249\u20131255","journal-title":"N Engl J Med"},{"key":"1025_CR33","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1210\/jc.2014-3441","volume":"100","author":"K Lundstam","year":"2015","unstructured":"Lundstam K, Heck A, Mollerup C et al (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100:1359\u20131367","journal-title":"J Clin Endocrinol Metab"},{"key":"1025_CR34","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"Eastell R, Brandi ML, Costa AG, D\u2019Amour P, Shoback DM, Thakker RV (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99:3570\u20133579","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-019-01025-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01025-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01025-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T11:37:30Z","timestamp":1662982650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-019-01025-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1025"],"URL":"https:\/\/doi.org\/10.1007\/s40618-019-01025-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"31 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained for all individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}